By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Shire Pharmaceuticals Group plc 

Hampshire International Business Park
Basingstoke  Hampshire  RG24 8EP  United Kingdom
Phone: 44-1256-894-000 Fax: 44-1256-894-708



Company News
Shire (SHPG) Release: ONIVYDE Receives Positive CHMP Opinion For Treatment Of Patients With Metastatic Adenocarcinoma Of The Pancreas Who Have Progressed Following Gemcitabine Based Therapy 7/25/2016 6:30:59 AM
Shire (SHPG) Launches Pediatric Indication For Immunodeficiency Treatment Hyqvia In Europe 7/21/2016 6:39:15 AM
Chronos Scoops Up Three Pre-clinical Programs From Shire (SHPG) for Undisclosed Sum 7/20/2016 5:55:21 AM
Shire (SHPG) Reinforces Commitment In Hematology With Robust Data Presented At International Congress Of The World Federation Of Hemophilia 7/19/2016 9:20:41 AM
Why Drugmakers like Merck & Co. (MRK), Shire (SHPG) and AstraZeneca PLC (AZN) Leave Philadelphia for Boston 7/18/2016 6:35:10 AM
Shire (SHPG) Soars After the FDA Approves Long-Awaited Dry-Eye Disease Drug 7/12/2016 6:31:57 AM
As Shire (SHPG) Closes on Baxalta (BXLT), David Meek Takes the Helm at Ipsen (IPN.PA) 7/11/2016 6:16:09 AM
Shire (SHPG) Receives Extension Of Market Authorization In Europe For Revestive (Teduglutide) For The Treatment Of Paediatric Patients With Short Bowel Syndrome (SBS) 7/7/2016 6:25:57 AM
Shire (SHPG)'s Retinopathy Treatment Fails to Meet Primary Endpoint in Phase II 6/30/2016 6:20:12 AM
As Stock Rises and Baxalta (BXLT) Merger Closes, Shire (SHPG) Opens New HQ in Massachusetts with 800 Jobs 6/29/2016 6:43:18 AM